Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (avaa uuden ikkunan)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Lähde‎: N Engl J Med 1998;338(8):499-505.

Arkistoitu‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (avaa uuden ikkunan)

Childhood cancer and the Jehovah's Witness faith. (avaa uuden ikkunan)

Frankel LS, Damme CJ, Eys JV.

Lähde‎: Pediatrics 1977;60(6):916-21.

Arkistoitu‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (avaa uuden ikkunan)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (avaa uuden ikkunan)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Lähde‎: J Clin Oncol 2004;22(24):4888-92.

Arkistoitu‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (avaa uuden ikkunan)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (avaa uuden ikkunan)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Lähde‎: JAMA Oncol 2022;8(1):79-87. 

Arkistoitu‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (avaa uuden ikkunan)

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. (avaa uuden ikkunan)

Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.

Lähde‎: Hematol Oncol 2014;32(1):40-6.

Arkistoitu‎: PubMed 23963734

DOI‎: 10.1002/hon.2076

https://www.ncbi.nlm.nih.gov/pubmed/23963734 (avaa uuden ikkunan)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (avaa uuden ikkunan)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Lähde‎: Haematologica 2000;85(11):1221-2.

Arkistoitu‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (avaa uuden ikkunan)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (avaa uuden ikkunan)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Lähde‎: Bone Marrow Transplant 2016;51(7):1002-3.

Arkistoitu‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (avaa uuden ikkunan)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (avaa uuden ikkunan)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Lähde‎: Bone Marrow Transplant 2003;32(4):433-6.

Arkistoitu‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (avaa uuden ikkunan)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (avaa uuden ikkunan)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Lähde‎: Bone Marrow Transplant 2005;36(8):715-20.

Arkistoitu‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (avaa uuden ikkunan)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (avaa uuden ikkunan)

Zwaan CM, Kaspers GJ

Lähde‎: Br J Haematol 2004;127(3):264-79.

Arkistoitu‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (avaa uuden ikkunan)

Tratamiento de la leucemia aguda linfoblástica con poliquimioterapia sin hemoderivados en niños Testigos de Jehová​. [Treatment of acute lymphoblastic leukemia using combination chemotherapy without blood-derived products in Jehovah's Witness children. (avaa uuden ikkunan)

​Tenorio-Guajardo G, Ferrer-Argote VE, Glender-Díaz W, Collazo-Jaloma J

Lähde‎: Rev Med Hosp Gen Mex 2009;72(1):16-9.

Arkistoitu‎: ISSN 0185-1063

https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=21009 (avaa uuden ikkunan)